The value of transrectal ultrasound in judging the course of spermatocystitis and determining the therapeutic schedule

LU Min-hua,HE Qing-qing,ZHANG Hao,XIAO Heng-jun,LIU Xiao-peng,GAO Xin,ZHANG Yan

DOI: https://doi.org/10.3877/cma.j.issn.1674-3253.2013.06.012

2013-01-01

Abstract:Objectives To analyze the value of transrectal ultrasound(TRUS) in judging the course of spermatocystitis and determining the therapeutic strategy. Methods The transrectal ultrasound results of 118 patients which were diagnosed spermatocystitis with hemospermia in outpatient service with following therapy during June of 2008 to February of 2012 were reviewed. Results The ultrasonic manifestations of 118 patients who were diagnosed spermatocystitis can be divided into three categories. The first class(78 cases): patients showed the increased volume of seminal vesicle, lower echo, and dilated tubular dark areas. The second class(30 cases): the bilateral seminal vesicle size were normal following with uneven echo. The third class(10 cases): the volume of bilateral seminal vesicle were normal, and calcification spots or ejaculation tube calcification could be found. The three ultrasonic manifestations were respectively correlated with acute spermatocystitis or acute attack stage of chronic spermatocystitis, chronic spermatocystitis, the chronic spermatocystitis with disease course for more than 10 years. The coincidence rate is greater than 90%. The therapy strategies were chosen according to the ultrasound manifestations. Conservative therapy and anti-infection were chosen to treat acute spermatocystitis, and transurethral seminal vesiculoscopy was chosen to treat chronic or calcificated spermatocystitis. The curative effect was satisfying. Conclusions To determine the stages of disease course and then to choose the treatment strategy according to transrectal ultrasound findings in patients with spermatocystitis was reliable,convenient and effective.